相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Differential effects on human cytochromes P450 by CRISPR/Cas9-induced genetic knockout of cytochrome P450 reductase and cytochrome b5 in HepaRG cells
Tamara Heintze et al.
SCIENTIFIC REPORTS (2021)
How circadian variability of the heart rate and plasma electrolytes concentration influence the cardiac electrophysiology - model-based case study
Barbara Wisniowska et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2021)
The Role of Epoxyeicosatrienoic Acids in Cardiac Remodeling
Jinsheng Lai et al.
FRONTIERS IN PHYSIOLOGY (2021)
Successful treatment of bepridil-induced intraoperative torsades de pointes by isoproterenol infusion
Ken Shimano et al.
JA CLINICAL REPORTS (2021)
Atypical kinetics of cytochrome P450 2J2: Epoxidation of arachidonic acid and reversible inhibition by xenobiotic inhibitors
Jacqueline Wen Hui Leow et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2021)
Evolving approaches on measurements and applications of intracellular free drug concentration and Kpuu in drug discovery
Li Di et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2021)
The Central Role of Cytochrome P450 in Xenobiotic Metabolism-A Brief Review on a Fascinating Enzyme Family
Francisco Esteves et al.
JOURNAL OF XENOBIOTICS (2021)
CYP2J2/EET reduces vulnerability to atrial fibrillation in chronic pressure overload mice
Xuguang Li et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Improving prediction of torsadogenic risk in the CiPA in silico model by appropriately accounting for clinical exposure
Derek J. Leishman
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2020)
Concentration Dependence of the Unbound Partition Coefficient Kpuu and Its Application to Correct for Exposure-Related Discrepancies between Biochemical and Cellular Potency of KAT6A Inhibitors
Cornelius Truenkle et al.
DRUG METABOLISM AND DISPOSITION (2020)
Clinical Studies on Drug-Drug Interactions Involving Metabolism and Transport: Methodology, Pitfalls, and Interpretation
Aleksi Tornio et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
Positron Emission Tomography Imaging of [11C]Rosuvastatin Hepatic Concentrations and Hepatobiliary Transport in Humans in the Absence and Presence of Cyclosporin A
Sarah Billington et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
Overview of the Components of Cardiac Metabolism
Elizabeth A. Hausner et al.
DRUG METABOLISM AND DISPOSITION (2019)
Impact of Intracellular Concentrations on Metabolic Drug-Drug Interaction Studies
Andrea Treyer et al.
AAPS JOURNAL (2019)
Inhibitory effects of antihypertensive drugs on human cytochrome P450 2J2 activity: Potent inhibition by azelnidipine and manidipine
Noriaki Ikemura et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2019)
NADPH-cytochrome P450 reductase expression and enzymatic activity in primary-like human hepatocytes and HepG2 cells for in vitro biotransformation studies
Christian Schulz et al.
CLINICAL HEMORHEOLOGY AND MICROCIRCULATION (2019)
Conflicting Roles of 20-HETE in Hypertension and Stroke
Shashank Shekhar et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Evaluating vandetanib in the treatment of medullary thyroid cancer: patient-reported outcomes
Poupak Fallahi et al.
CANCER MANAGEMENT AND RESEARCH (2019)
Atypical Michaelis-Menten kinetics in cytochrome P450 enzymes: A focus on substrate inhibition
Jacqueline Wen Hui Leow et al.
BIOCHEMICAL PHARMACOLOGY (2019)
Evaluation of Possible Proarrhythmic Potency: Comparison of the Effect of Dofetilide, Cisapride, Sotalol, Terfenadine, and Verapamil on hERG and Native IKr Currents and on Cardiac Action Potential
Peter Orvos et al.
TOXICOLOGICAL SCIENCES (2019)
Today's Challenges to De-Risk and Predict Drug Safety in Human Mind-the-Gap
Richard J. Weaver et al.
TOXICOLOGICAL SCIENCES (2019)
Theoretical Considerations for Direct Translation of Unbound Liver-to-Plasma Partition Coefficient from In Vitro to In Vivo
Zhenhong Li et al.
AAPS JOURNAL (2019)
A Clinical Quantitative Evaluation of Hepatobiliary Transport of [11C] Dehydropravastatin in Humans Using Positron Emission Tomography
Ken-Ichi Kaneko et al.
DRUG METABOLISM AND DISPOSITION (2018)
Human Induced Pluripotent Stem Cell (hiPSC)-Derived Cells to Assess Drug Cardiotoxicity: Opportunities and Problems
Tarek Magdy et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 58 (2018)
Therapeutic potential of omega-3 fatty acid-derived epoxyeicosanoids in cardiovascular and inflammatory diseases
Wolf-Hagen Schunck et al.
PHARMACOLOGY & THERAPEUTICS (2018)
International Multisite Study of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Drug Proarrhythmic Potential Assessment
Ksenia Blinova et al.
CELL REPORTS (2018)
Modernized Classification of Cardiac Antiarrhythmic Drugs
Ming Lei et al.
CIRCULATION (2018)
Beyond drug-drug interactions: effects of transporter inhibition on endobiotics, nutrients and toxins
Eve-irene Lepist et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2017)
Cytochrome P450-derived eicosanoids and heart function
K. Lockhart Jamieson et al.
PHARMACOLOGY & THERAPEUTICS (2017)
Actions and Mechanisms of Polyunsaturated Fatty Acidson Voltage-Gated Ion Channels
Fredrik Elinder et al.
FRONTIERS IN PHYSIOLOGY (2017)
Effects of dronedarone, amiodarone and their active metabolites on sequential metabolism of arachidonic acid to epoxyeicosatrienoic and dihydroxyeicosatrienoic acids
Aneesh Karkhanis et al.
BIOCHEMICAL PHARMACOLOGY (2017)
Two cases of life-threatening arrhythmia induced by risperidone: evaluation of risperidone and 9-hydroxy-risperidone concentrations
Asami Ito et al.
ACUTE MEDICINE & SURGERY (2017)
Inhibition and inactivation of human CYP2J2: Implications in cardiac pathophysiology and opportunities in cancer therapy
Aneesh Karkhanis et al.
BIOCHEMICAL PHARMACOLOGY (2017)
Novel Method to Predict In Vivo Liver-to-Plasma Kpuu for OATP Substrates Using Suspension Hepatocytes
Keith Riccardi et al.
DRUG METABOLISM AND DISPOSITION (2017)
Multiple modes of inhibition of human cytochrome P450 2J2 by dronedarone, amiodarone and their active metabolites
Aneesh Karkhanis et al.
BIOCHEMICAL PHARMACOLOGY (2016)
Molecular Mechanisms and New Treatment Paradigm for Atrial Fibrillation
Padmini Sirish et al.
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2016)
Evolution of strategies to improve preclinical cardiac safety testing
Gary Gintant et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
The role of 20-HETE in cardiovascular diseases and its risk factors
Maayan Waldman et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2016)
The Comprehensive in Vitro Proarrhythmia Assay (CiPA) initiative Update on progress
Thomas Colatsky et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2016)
Determination of Unbound Partition Coefficient and in Vitro-in Vivo Extrapolation for SLC13A Transporter-Mediated Uptake
Keith Riccardi et al.
DRUG METABOLISM AND DISPOSITION (2016)
Correlation of Cytochrome P450 Oxidoreductase Expression with the Expression of 10 Isoforms of Cytochrome P450 in Human Liver
Hai-Feng Zhang et al.
DRUG METABOLISM AND DISPOSITION (2016)
Cardiomyocyte-specific expression of CYP2J2 prevents development of cardiac remodelling induced by angiotensin II
Zuowen He et al.
CARDIOVASCULAR RESEARCH (2015)
Domperidone, cytochrome P450 3A4 isoenzyme inhibitors and ventricular arrhythmia: a nationwide case-crossover study
Hung-Lin Chen et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2015)
Advances in Our Understanding of Oxylipins Derived from Dietary PUFAs
Melissa Gabbs et al.
ADVANCES IN NUTRITION (2015)
The effects of six antipsychotic agents on QTc-An attempt to mimic clinical trial through simulation including variability in the population
Anna Glinka et al.
COMPUTERS IN BIOLOGY AND MEDICINE (2014)
Research/Review: Insights into the Mutation-Induced Dysfunction of Arachidonic Acid Metabolism from Modeling of Human CYP2J2
Xiao-Le Xia et al.
CURRENT DRUG METABOLISM (2014)
The Revised Human Liver Cytochrome P450 Pie: Absolute Protein Quantification of CYP4F and CYP3A Enzymes Using Targeted Quantitative Proteomics
Scott Michaels et al.
DRUG METABOLISM AND DISPOSITION (2014)
Clinical significance of organic anion transporting polypeptides (OATPs) in drug disposition: their roles in hepatic clearance and intestinal absorption
Yoshihisa Shitara et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2013)
Renal drug metabolism in humans: the potential for drug-endobiotic interactions involving cytochrome P450 (CYP) and UDP-glucuronosyltransferase (UGT)
Kathleen M. Knights et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Factors Involved in Extracellular Matrix Turnover in Human Derived Cardiomyocytes
Gregori Casals et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2013)
Cytochromes P450: Roles in Diseases
Irina A. Pikuleva et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Rapid Measurement of Intracellular Unbound Drug Concentrations
Andre Mateus et al.
MOLECULAR PHARMACEUTICS (2013)
CYP2J2 Overexpression Protects against Arrhythmia Susceptibility in Cardiac Hypertrophy
Christina Westphal et al.
PLOS ONE (2013)
Discovery and Characterization of Novel, Potent, and Selective Cytochrome P450 2J2 Inhibitors
Shuang Ren et al.
DRUG METABOLISM AND DISPOSITION (2013)
Activity, Inhibition, and Induction of Cytochrome P450 2J2 in Adult Human Primary Cardiomyocytes
Eric A. Evangelista et al.
DRUG METABOLISM AND DISPOSITION (2013)
Evidence That Cytochrome b5 and Cytochrome b5 Reductase Can Act as Sole Electron Donors to the Hepatic Cytochrome P450 Systems
Colin J. Henderson et al.
MOLECULAR PHARMACOLOGY (2013)
QT prolongation of the antipsychotic risperidone is predominantly related to its 9-hydroxy metabolite paliperidone
Yutaro Suzuki et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2012)
Molecular determinants of hERG potassium channel inhibition by disopyramide
Aziza El Harchi et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2012)
Proarrhythmic Potential of Dronedarone: Emerging Evidence from Spontaneous Adverse Event Reporting
David P. Kao et al.
PHARMACOTHERAPY (2012)
Identifying a Selective Substrate and Inhibitor Pair for the Evaluation of CYP2J2 Activity
Caroline A. Lee et al.
DRUG METABOLISM AND DISPOSITION (2012)
Cisapride: What can we learn from the rise and fall of a prokinetic?
Eamonn M. M. Quigley
JOURNAL OF DIGESTIVE DISEASES (2011)
CYP3A5-mediated metabolism of midazolam in recombinant systems is highly sensitive to NADPH-cytochrome P450 reductase activity
Hege Christensen et al.
XENOBIOTICA (2011)
Identification of Novel Substrates for Human Cytochrome P450 2J2
Caroline A. Lee et al.
DRUG METABOLISM AND DISPOSITION (2010)
Aldosterone glucuronidation by human liver and kidney microsomes and recombinant UDP-glucuronosyltransferases: Inhibition by NSAIDs
Kathleen M. Knights et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Xenobiotic-Metabolizing Enzymes and Transporters in the Normal Human Brain: Regional and Cellular Mapping as a Basis for Putative Roles in Cerebral Function
Fabien Dutheil et al.
DRUG METABOLISM AND DISPOSITION (2009)
Different Enzyme Kinetics of Midazolam in Recombinant CYP3A4 Microsomes from Human and Insect Sources
Hege Christensen et al.
DRUG METABOLISM AND PHARMACOKINETICS (2009)
The Organic Cation Transporter, OCTN1, Expressed in the Human Heart, Potentiates Antagonism of the HERG Potassium Channel
Brian F. McBride et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2009)
Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation
Ulrich M. Zanger et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2008)
Arachidonic acid and ion channels: an update
H. Meves
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Soluble epoxide hydrolase is a susceptibility factor for heart failure in a rat model of human disease
Jan Monti et al.
NATURE GENETICS (2008)
Electrophysiological properties of cardiomyocytes isolated from CYP2J2 transgenic mice
Qingen Ke et al.
MOLECULAR PHARMACOLOGY (2007)
Reverse transcriptase-PCR quantification of mRNA levels from cytochrome (CYP)1, CYP2 and CYP3 families in 22 different human tissues
Ivan Bieche et al.
PHARMACOGENETICS AND GENOMICS (2007)
Cyclic AMP-dependent modulation of cardiac L-type Ca2+ and transient outward K+ channel activities by epoxyeicosatrienoic acids
Yong-Fu Xiao
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2007)
Cytochrome P450 enzymes: Central players in cardiovascular health and disease
Reem H. Elbekai et al.
PHARMACOLOGY & THERAPEUTICS (2006)
Design and synthesis of selective, high-affinity inhibitors of human cytochrome P450 2J2
P Lafite et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Intravenous droperidol - A review of its use in the management of postoperative nausea and vomiting
Kate McKeage et al.
DRUGS (2006)
Refining detection of drug-induced proarrhythmia: QT interval and TRIaD
RR Shah et al.
HEART RHYTHM (2005)
Novel cell lines derived from adult human ventricular cardiomyocytes
MM Davidson et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2005)
Drugs, QTc interval prolongation and final ICH E14 guideline - An important milestone with challenges ahead
RR Shah
DRUG SAFETY (2005)
Distribution of soluble epoxide hydrolase and of cytochrome P4502C8, 2C9, and 2J2 in human tissues
AE Enayetallah et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2004)
Multisite kinetic analysis of interactions between prototypical CYP3A4 subgroup substrates: Midazolam, testosterone, and nifedipine
A Galetin et al.
DRUG METABOLISM AND DISPOSITION (2003)
Involvement of CYP2J2 on the intestinal first-pass metabolism of antihistamine drug, astemizole
S Matsumoto et al.
DRUG METABOLISM AND DISPOSITION (2002)
分享论文
